[go: up one dir, main page]

Cornell et al., 1972 - Google Patents

Effect of plasma and platelet concentrate infusions on factor VIII, platelet adhesiveness, and bleeding time in bleeder swine

Cornell et al., 1972

Document ID
7532137377997432796
Author
Cornell C
Cooper R
Muhrer M
Garb S
Publication year
Publication venue
Thrombosis and Haemostasis

External Links

Snippet

Bleeder swine are characterized by a prolonged bleeding time, decreased factor VIII levels or reduced platelet adhesiveness or both, and a factor VIII response to infusion of plasma or serum similar to that described in von Willebrand's disease. In this study the factor VIII …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
Gawaz et al. Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease.
Larrieu et al. Congenital bleeding disorders with long bleeding time and normal platelet count: II. Von Willebrand's disease (report of thirty-seven patients)
Weiss et al. Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease
Ruggeri et al. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes
Ludlam et al. Factor VIII and fibrinolytic response to deamino‐8‐D‐argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease
DE69032559T2 (en) BLOOD PLATE MEMBRANE MICROPARTICLES
Southern et al. Unwashed Wound Drainage Blood What Are We Giving Our Patients?.
Gelfand et al. Alternative complement pathway activation increases mortality in a model of burn injury in mice.
Sampson et al. Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases
WO2008135983A2 (en) Recombinant human fibrinogen for treatment of bleeding in trauma and platelet disorders
Ma et al. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion.
Wessler et al. A distinction between the role of precursor and activated forms of clotting factors in the genesis of stasis thrombi
Loeliger et al. Substitution therapy in haemophilia B
MARENGO-ROWE et al. Hemophilia-like disease associated with pregnancy
Weiss The use of plasma and plasma fractions in the treatment of a patient with von Willebrand's disease
Rick Diagnosis and management of von Willebrand's syndrome
Rush et al. The treatment of patients with factor-V deficiency
RAMOT et al. Plasma Thromboplastin Antecedent: Deficiency
McKIE et al. Coagulopathy complicating intraoperative blood salvage in a patient who had idiopathic scoliosis. A case report
Cornell et al. Effect of plasma and platelet concentrate infusions on factor VIII, platelet adhesiveness, and bleeding time in bleeder swine
Cameron et al. Perioperative management of patients with von Willebrand’s disease
Chaplin Jr et al. Frozen storage of 11 units of sickle cell red cells for autologous transfusion of a single patient
COOKE et al. Cryoprecipitate concentrates of factor VIII for surgery in hemophiliacs
Lethagen et al. Blood loss and safety with desmopressin or placebo during aorto-iliac graft surgery
Stokol et al. Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A